Showing 1 - 3 results of 3 for search 'Felix E. deJongh', query time: 0.02s Refine Results
  1. 1
    Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands

    Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands by Felix E. de Jongh, Reva Efe, Kirsten H. Herrmann, Jelle A. Spoorendonk

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

    Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial by Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Geert‐Jan M. Creemers, Frans L. G. Erdkamp, Felix E. deJongh, Peter A. M. Kint, Boelo J. Poppema, Sandra A. Radema, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman, Anne M. May

    Published 2020-02-01
    Get full text
    Article
  3. 3
    Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study

    Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study by Ruben Y.M. van Nijnatten, Sanne M. Buijs, Bram C. Agema, Raphaël M.J. Fischer, Inge Ghobadi Moghaddam-Helmantel, Caroline M.E. Contant, Felix E. de Jongh, Auke M.T. Huijben, Manon Kop, Annemieke van der Padt-Pruijsten, Hanneke J.M. Zuetenhorst, Ron H.N. van Schaik, Birgit C.P. Koch, A. Jager, Stijn L.W. Koolen, Ron H.J. Mathijssen

    Published 2025-02-01
    Get full text
    Article

Search Tools: